Difference between revisions of "Electrodesiccation and curettage"
Jump to navigation
Jump to search
(+SO) |
|||
| Line 12: | Line 12: | ||
**The [[pathologist]] cannot comment on whether the margin is clear or the [[surgical clearance]]. | **The [[pathologist]] cannot comment on whether the margin is clear or the [[surgical clearance]]. | ||
*The size of the lesion is usually impossible to determine on pathology. | *The size of the lesion is usually impossible to determine on pathology. | ||
==Sign out== | |||
<pre> | |||
Skin, Right Shoulder, Biopsy with Curettage and Electrodesiccation (CED): | |||
- BASAL CELL CARCINOMA, margin status assessed clinically during CED. | |||
</pre> | |||
==References== | ==References== | ||
Revision as of 16:03, 3 December 2021
Electrodesiccation and curettage, abbreviated EDC and E+C, is a procedure in which:
- The lesion is cut-off (sent to pathology).
- The surgical site is cauterized using electricity (electrodesiccation).
- The electrodesiccated tissue is scrapped off (curettage).
General
- EDCs are typically done by family physicians and dermatologists for non-melanoma skin cancers.[1]
- The practise is not without controversy.[1][2]
Limitations of the technique are:
- The margin status is assessed clinically.
- The pathologist cannot comment on whether the margin is clear or the surgical clearance.
- The size of the lesion is usually impossible to determine on pathology.
Sign out
Skin, Right Shoulder, Biopsy with Curettage and Electrodesiccation (CED): - BASAL CELL CARCINOMA, margin status assessed clinically during CED.
References
- ↑ 1.0 1.1 Goldman, G. (Jul 2002). "The current status of curettage and electrodesiccation.". Dermatol Clin 20 (3): 569-78, ix. PMID 12170889.
- ↑ Reschly, MJ.; Shenefelt, PD. (Jul 2010). "Controversies in skin surgery: electrodessication and curettage versus excision for low-risk, small, well-differentiated squamous cell carcinomas.". J Drugs Dermatol 9 (7): 773-6. PMID 20677531.